78 related articles for article (PubMed ID: 7938907)
21. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse.
McArdle A; Edwards RH; Jackson MJ
Muscle Nerve; 1994 Dec; 17(12):1378-84. PubMed ID: 7969238
[TBL] [Abstract][Full Text] [Related]
22. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
23. Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers.
Suh JG; Yamazaki A; Tomita T
Lab Anim Sci; 1994 Feb; 44(1):42-6. PubMed ID: 8007658
[TBL] [Abstract][Full Text] [Related]
24. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
Larochelle N; Oualikene W; Dunant P; Massie B; Karpati G; Nalbantoglu J; Lochmuller H
Biochem Biophys Res Commun; 2002 Apr; 292(3):626-31. PubMed ID: 11922612
[TBL] [Abstract][Full Text] [Related]
25. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice.
Braun S; Thioudellet C; Rodriguez P; Ali-Hadji D; Perraud F; Accart N; Balloul JM; Halluard C; Acres B; Cavallini B; Pavirani A
Gene Ther; 2000 Sep; 7(17):1447-57. PubMed ID: 11001364
[TBL] [Abstract][Full Text] [Related]
26. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
[TBL] [Abstract][Full Text] [Related]
27. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
Ui H; Andoh T; Lee JB; Nojima H; Kuraishi Y
Eur J Pharmacol; 2006 Jan; 530(1-2):172-8. PubMed ID: 16359660
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
29. The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle.
Anderson JE; Liu L; Kardami E
Muscle Nerve; 1994 Jan; 17(1):64-73. PubMed ID: 8264704
[TBL] [Abstract][Full Text] [Related]
30. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
31. Extracts from mdx and normal mouse skeletal muscle contain similar levels of mitogenic activity for myoblasts.
Chen G; Bressler BH; Quinn LS
Cell Biol Int; 1994 Apr; 18(4):229-35. PubMed ID: 8044140
[TBL] [Abstract][Full Text] [Related]
32. Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation.
Murakami T; Nishi T; Kimura E; Goto T; Maeda Y; Ushio Y; Uchino M; Sunada Y
Muscle Nerve; 2003 Feb; 27(2):237-41. PubMed ID: 12548532
[TBL] [Abstract][Full Text] [Related]
33. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
Williams JH; Sirsi SR; Latta DR; Lutz GJ
Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
[TBL] [Abstract][Full Text] [Related]
34. Voluntary exercise induces structural remodeling in the hearts of dystrophin-deficient mice.
Costas JM; Nye DJ; Henley JB; Plochocki JH
Muscle Nerve; 2010 Dec; 42(6):881-5. PubMed ID: 21104863
[TBL] [Abstract][Full Text] [Related]
35. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse.
McArdle A; Edwards RH; Jackson MJ
Clin Sci (Lond); 1991 Apr; 80(4):367-71. PubMed ID: 1851074
[TBL] [Abstract][Full Text] [Related]
36. Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis.
Gorospe JR; Tharp M; Demitsu T; Hoffman EP
Neuromuscul Disord; 1994 Jul; 4(4):325-33. PubMed ID: 7981589
[TBL] [Abstract][Full Text] [Related]
37. Muscle damage in mdx mice.
Jackson MJ; McArdle A; Edwards RH; Jones DA
Nature; 1991 Apr; 350(6320):664. PubMed ID: 2023630
[No Abstract] [Full Text] [Related]
38. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice.
Reeve JL; McArdle A; Jackson MJ
Muscle Nerve; 1997 Mar; 20(3):357-60. PubMed ID: 9052816
[No Abstract] [Full Text] [Related]
39. Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection.
Danko I; Fritz JD; Latendresse JS; Herweijer H; Schultz E; Wolff JA
Hum Mol Genet; 1993 Dec; 2(12):2055-61. PubMed ID: 8111373
[TBL] [Abstract][Full Text] [Related]
40. Recruitment of mast cells to muscle after mild damage.
Gorospe JR; Nishikawa BK; Hoffman EP
J Neurol Sci; 1996 Jan; 135(1):10-7. PubMed ID: 8926490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
